Pegstim 6MG Injection (0.6ml) is a medication that contains Pegfilgrastim, a biologically engineered form of human granulocyte colony-stimulating factor (G-CSF). This drug is primarily used to stimulate the production of white blood cells, specifically neutrophils, which are crucial for fighting infections. Pegstim is commonly prescribed to patients undergoing chemotherapy, as these treatments can significantly lower white blood cell counts, leading to an increased risk of infections. The injection is designed to be administered subcutaneously, typically once per chemotherapy cycle, and its formulation allows for a longer duration of action compared to other G-CSF products. By enhancing the body’s natural ability to produce neutrophils, Pegstim helps reduce the incidence of febrile neutropenia, a serious complication associated with chemotherapy. Overall, Pegstim 6MG Injection plays a vital role in improving the safety and efficacy of cancer treatment by supporting the immune system.